VAERS reports by lot

Moderna COVID-19 lot 058A222A: VAERS reports

112 VAERS reports list lot 058A222A as a Moderna COVID-19 vaccine, received between 2022-05-29 and 2023-12-22. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
112
Reports
8%
Marked serious
1
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4022%
Respiratory2916%
Gastrointestinal2916%
Cardiac / Cardiovascular2312%
Neurological2212%
Dermatological (non-injection-site)126%
Injection-site / Local reaction116%
Allergic / Anaphylactic84%
Thrombotic / Hematological42%
Musculoskeletal42%
Psychiatric / Neuropsychiatric21%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Arizona72
California5
Michigan5
Ohio4
New York3
Virginia2
Alabama2
Texas2
Connecticut2
Missouri1
Nebraska1
New Mexico1

Reports by month received

2022-051
2022-0613
2022-0710
2022-0874
2022-091
2022-101
2022-124
2023-011
2023-064
2023-071
2023-122

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.